Modiquest Research B.V. Our company, founded early 2005 as a private company, is a contract research provider focused on the generation of (recombinant) monoclonal antibodies from various species. We are a young and dynamic biotech company specialized in high throughput generation of human and animal (recombinant) antibodies, especially for application in the fields of autoimmune diseases, infectious diseases, and cancer. Antibodies are generated using a large panel of state-of-the art technologies and can be used for diagnostic and therapeutic purposes. To provide its high quality services, the company uses ultra modern facilities with state-of-the-art equipment, has a staff of highly skilled and experienced employees, and holds licenses for various antibody technologies. It works for large and small leading pharmaceutical and diagnostic companies. In addition our company supports academic research programs.